Tuberculosis kills around 1.3 million people each year, and a rapid diagnostic test to enable better clinical decisions to be made through the real-time monitoring of TB disease during treatment is urgently needed.

TB-MBLA is a RT-qPCR test that can detect and estimate the TB burden in patient sputum samples.

In collaboration with The University of St Andrews, LifeArc has developed the TB-MBLA RUO kit. The TB-MBLA will be used in research studies where patient samples will be tested to build clinical evidence that demonstrates the benefits of TB-MBLA as a diagnostic and treatment monitoring tool over current methods.

TB-MBLA research use only kit resources

The TB-MBLA Instructions for Use (IFU) and Material Safety Data Sheets (MSDS) can be found below.

Instructions for use

TB-MBLA IFU (PDF – 288 KB)

MSDS

TB-MBLA Extraction Control (PDF – 181 KB)
TB-MBLA RNA Standard (PDF – 224 KB)
TB-MBLA Assay Mix (PDF – 191 KB)
TB-MBLA RNAse-Free Water (PDF – 121 KB)
TB-MBLA qPCR MasterMix (PDF – 148 KB)
TB-MBLA Reverse Transcriptase (PDF – 143 KB)

The video below describes the main steps of the TB-MBLA protocol and may be used to support training activities.

For further assistance, please contact us using the form below.

Contact the TB-MBLA Team

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email dataprivacy@lifearc.org.
    Please see our Privacy policy in relation to the personal data you submit to us through this page.